Primary Site >> Liver Cancer

Gene >> SLC5A8

  • 1989
  • 1991
  • 1993
  • 1999
  • 2002
  • 2004
  • 2010
  • 2011
  • 2012
  • 2014
  • 2016
  • 2017
  • 2018
Ref: [The therapeutic effects of OK-432 combined adoptive immunotherapy (AIT) against liver metastases of breast cancer].
PMID: 2730083
Ref: [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
PMID: 2786379
 Ref: [LAK cell adoptive immunotherapy and its problems].
PMID: 1944194
 Ref: Presence of viral replicative intermediates in the liver and serum of patients infected with hepatitis C virus.
PMID: 8387574
 Ref: Clinical application of adoptive immunotherapy and IL-2 for the treatment of advanced digestive tract cancer.
PMID: 10429974
 Ref: Locoregional immuno(bio)therapy for liver metastases.
PMID: 11951214
 Ref: Effective separation of potent antiproliferation and antiadhesion components from wild blueberry (Vaccinium angustifolium Ait.) fruits.
PMID: 15479003
 Ref: Effects of matrine on HepG2 cell proliferation and expression of tumor relevant proteins in vitro.
PMID: 20645813
 Ref: In vitro anti-tumour activities of quinolizidine alkaloids derived from Sophora flavescens Ait.
PMID: 21159130
 Ref: Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.
PMID: 22171902
 Ref: Ligustrum lucidum Ait. fruit extract induces apoptosis and cell senescence in human hepatocellular carcinoma cells through upregulation of p21.
PMID: 25017491
Ref: Potentiation of resveratrol-induced apoptosis by matrine in human hepatoma HepG2 cells.
PMID: 25269486
 Ref: Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/beta-catenin signaling.
PMID: 27465549
Ref: Synthesis and biological evaluation of matrine derivatives containing benzo-alpha-pyrone structure as potent anti-lung cancer agents.
PMID: 27786281
 Ref: A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways.
PMID: 27773936
Ref: Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review.
PMID: 28061472
Ref: Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.
PMID: 28339493
 Ref: A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma.
PMID: 29970657